High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study

Background: Coronavirus disease 2019 (COVID-19) pandemic is continuing to impact multiple countries worldwide and effective treatment options are still being developed. In this study, we investigate the potential of high-dose intravenous vitamin C (HDIVC) in the prevention of moderate COVID-19 disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Bing, Liu, Min, Liu, Ping, Peng, Yibing, Huang, Jun, Li, Mengjiao, Wang, Yihui, Xu, LiLi, Sun, Silei, Qi, Xing, Ling, Yun, Li, Jian, Zhang, Wenhong, Mao, Enqiang, Qu, Jieming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100592/
https://www.ncbi.nlm.nih.gov/pubmed/33967773
http://dx.doi.org/10.3389/fphar.2021.638556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100592/
https://www.ncbi.nlm.nih.gov/pubmed/33967773
http://dx.doi.org/10.3389/fphar.2021.638556

Ejemplares similares